# Surgical Outcomes of Epiretinal Human Amniotic Membrane Transplantation for Refractory Macular Holes

**Authors:** Sibel Doguizi, Cemile Ucgul Atilgan, Kemal Tekin

PMC · DOI: 10.3390/jcm15041443 · 2026-02-12

## TL;DR

This study shows that using human amniotic membrane surgery can successfully close difficult-to-treat macular holes and improve vision.

## Contribution

The study introduces epiretinal human amniotic membrane transplantation as a novel surgical approach for refractory macular holes.

## Key findings

- All 10 patients achieved complete anatomical closure of their macular holes.
- Visual acuity improved significantly after the procedure.
- Retinal layers were partially restored in 70% of patients.

## Abstract

Background/Objectives: Refractory macular holes (MHs) that persist after conventional internal limiting membrane (ILM) peeling pose a significant surgical challenge. In this study, we analyzed the anatomical and functional outcomes of epiretinal human amniotic membrane (hAM) transplantation in patients with MHs. Methods: This retrospective study included 10 eyes of 10 patients with refractory MHs. All patients underwent 25-gauge pars plana vitrectomy, epiretinal cryopreserved hAM transplantation, and C3F8 gas tamponade. The large hAM graft was placed over the macula with the stromal side facing the retina. Preoperative and postoperative best-corrected visual acuity (BCVA), optical coherence tomography (OCT) findings, and MH dimensions were recorded. Results: The mean follow-up period was 7 months (range: 3–14 months). The mean preoperative minimum linear diameter and base diameter of the MHs were 715 ± 212 μm and 1114 ± 258 μm, respectively. Anatomical closure was achieved in all patients (100%). Postoperative OCT revealed rearrangement of the inner and other retinal layers in 7 out of 10 patients (70%), with partial restoration of the outer retinal layers. The mean logMAR BCVA improved significantly from 1.60 ± 0.37 preoperatively to 1.00 ± 0.45 postoperatively (p < 0.001). No graft dislocation, rejection, or other significant complications were observed. Conclusions: Our preliminary results suggest that epiretinal human amniotic membrane transplantation is a feasible and promising surgical technique for achieving anatomical closure and functional improvement in refractory macular holes in which conventional ILM peeling has failed.

## Linked entities

- **Diseases:** macular holes (MONDO:0006843)

## Full-text entities

- **Genes:** NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}
- **Diseases:** RPE (MESH:C536309), visual field loss (MESH:D014786), epiretinal (MESH:D019773), inflammation (MESH:D007249), retinal neovascularization (MESH:D015861), scotoma (MESH:D012607), hypotony (MESH:D009123), injury to (MESH:D014947), MH (MESH:C535694), syphilis (MESH:D013587), fibrosis (MESH:D005355), gliosis (MESH:D005911), endophthalmitis (MESH:D009877), atrophy (MESH:D001284), high myopia (MESH:D009216), hepatitis B and C viruses (MESH:D006509), cystoid macular edema (MESH:D008269), vitreoretinal pathologies (MESH:D058499), diabetic retinopathy (MESH:D003930), retinal defect (MESH:D012173), RPE damage (MESH:D012164), EZ defects (MESH:D020179), cataract (MESH:D002386), ELM (MESH:D015433), BD (MESH:D015875), retinal vascular occlusion (MESH:D015356), MHs (MESH:D012167), RD (MESH:D012163), dislocation (MESH:D004204)
- **Chemicals:** salt (MESH:D012492), glycerol (MESH:D005990), perfluoropropane (MESH:C042852), PFCL (-), saline (MESH:D012965), ciprofloxacin (MESH:D002939), Brilliant Blue G (MESH:C004692), amphotericin B. (MESH:D000666), benzyl penicillin (MESH:D010400), steroid (MESH:D013256), silicone oil (MESH:D012827)
- **Species:** Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942158/full.md

---
Source: https://tomesphere.com/paper/PMC12942158